Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma

Annals of Surgical Oncology

Volumn 17, Issue 2, 2010, Pages 502-513

  Chu, Carrie K ^a   Mazo, Ashley E ^a   Goodman, Michael ^b   Egnatashvili, Vasili ^a   Sarmiento, Juan M ^a   Staley, Charles A ^a   Galloway, John R ^a   Adsay, N Volkan ^a   Jacobs, Sol ^a   Kooby, David A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PERINEURIUM; PREOPERATIVE PERIOD; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TUMOR LOCALIZATION; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77149175650     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0789-6     Document Type: Article

References (56)

1. R Bright 1833 Cases and observations connected with disease of the pancreas and duodenum Med Chir Trans. 18 1 56
2. American Cancer Society: Cancer Facts and Figures 2008. http://www.cancer.org/docroot/CRI/content/CRI-2-4-1X-What-are-the-key- statistics-for-pancreatic-cancer-34.asp?sitearea=. Accessed February 11, 2009.
3. Centers for Disease Control and Prevention: National Diabetes Fact Sheet, 2007. http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2007.pdf. Accessed February 12, 2009.
4. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414-31.
5. S Wild G Roglic A Green, et al. 2004 Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care. 27 5 1047 1053 10.2337/diacare.27.5.1047 15111519 (Pubitemid 38579764)
6. R Pannala JB Leirness WR Bamlet, et al. 2008 Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus Gastroenterology 134 4 981 987 10.1053/j.gastro.2008.01.039 1:CAS:528:DC%2BD1cXls1Gmurk%3D 18395079
7. ST Chari CL Leibson KG Rabe, et al. 2008 Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer Gastroenterology 134 1 95 101 10.1053/j.gastro.2007.10.040 1:CAS:528: DC%2BD1cXhtlehsbc%3D 18061176 (Pubitemid 350309328)
8. EL Wynder K Mabuchi N Maruchi JG Fortner 1973 Epidemiology of cancer of the pancreas J Natl Cancer Inst 50 3 645 667 1:STN:280:DyaE3s7oslCqtg%3D%3D 4350660
9. RA Hiatt AL Klatsky MA Armstrong 1988 Pancreatic cancer, blood glucose and beverage consumption Int J Cancer 41 6 794 797 10.1002/ijc.2910410603 1:STN:280:DyaL1c3islSnsA%3D%3D 3372055
10. V Kalapothaki A Tzonou CC Hsieh, et al. 1993 Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma Cancer Causes Control 4 4 375 382 10.1007/BF00051341 1:STN:280:DyaK3szltVWiuw%3D%3D 8347787
11. RJ Stevens AW Roddam V Beral 2007 Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis Br J Cancer 96 3 507 509 10.1038/sj.bjc.6603571 1:STN:280:DC%2BD2s%2FotlOhtg%3D%3D 17224924 (Pubitemid 46215224)
12. Batty GD, Kivimaki M, Morrison D, et al. Risk factors for pancreatic cancer mortality: extended follow-up of the original Whitehall study. Cancer Epidemiol Biomarkers Prev. 2009.
13. A Ansary-Moghaddam R Huxley F Barzi, et al. 2006 The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region Cancer Epidemiol Biomarkers Prev 15 12 2435 2440 10.1158/1055-9965.EPI- 06-0368 17164367 (Pubitemid 46048301)
14. EE Calle TK Murphy C Rodriguez, et al. 1998 Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults Cancer Causes Control 9 4 403 410 10.1023/A:1008819701485 1:STN:280: DyaK1M%2FgvVaktg%3D%3D 9794172 (Pubitemid 28466692)
15. L Gullo R Pezzilli AM Morselli-Labate 1994 Diabetes and the risk of pancreatic cancer N Engl J Med 331 2 81 84 10.1056/NEJM199407143310203 1:STN:280:DyaK2c3mvVGhug%3D%3D 8208269 (Pubitemid 24202222)
16. F Wang S Gupta EA Holly 2006 Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California Cancer Epidemiol Biomarkers Prev 15 8 1458 1463 10.1158/1055-9965.EPI-06-0188 16896032 (Pubitemid 44299315)
17. J Permert I Ihse L Jorfeldt, et al. 1993 Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer Br J Surg 80 8 1047 1050 10.1002/bjs.1800800841 1:STN:280:DyaK2c%2FgsFGrsw%3D%3D 8402064 (Pubitemid 23261595)
18. D Basso M Plebani P Fogar, et al. 1994 Beta-cell function in pancreatic adenocarcinoma Pancreas 9 3 332 335 10.1097/00006676-199405000-00008 1:STN:280:DyaK2c3psVensA%3D%3D 8022755
19. J Litwin S Dobrowolski E Orlowska-Kunikowska Z Sledzinski 2008 Changes in glucose metabolism after Kausch-Whipple pancreatectomy in pancreatic cancer and chronic pancreatitis patients Pancreas 36 1 26 30 10.1097/mpa.0b013e318137aa61 1:CAS:528:DC%2BD1cXhtVCgs7k%3D 18192877
20. RH Bell Jr S Place P McCullough, et al. 1986 Pancreatic insulin secretion in exocrine pancreatic cancer J Surg Res 40 6 588 596 10.1016/0022-4804(86) 90102-2 1:CAS:528:DyaL28XlvVymu70%3D 3528667 (Pubitemid 16033066)
21. J Liu JA Knezetic L Strommer, et al. 2000 The intracellular mechanism of insulin resistance in pancreatic cancer patients J Clin Endocrinol Metab 85 3 1232 1238 10.1210/jc.85.3.1232 1:CAS:528:DC%2BD3cXisFOqs7c%3D 10720068 (Pubitemid 32269378)
22. P Fogar D Basso MP Panozzo, et al. 1993 C-peptide pattern in patients with pancreatic cancer Anticancer Res 13 6 2577 2580 1:STN:280: DyaK2c7ot1yqtw%3D%3D 8135497
23. L Gullo D Ancona R Pezzilli, et al. 1993 Glucose tolerance and insulin secretion in pancreatic cancer Ital J Gastroenterol 25 9 487 489 1:STN:280:DyaK2c7mvFChtQ%3D%3D 8123896
24. RZ Stolzenberg-Solomon BI Graubard S Chari, et al. 2005 Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers JAMA 294 22 2872 2878 10.1001/jama.294.22.2872 1:CAS:528:DC%2BD2MXhtlWrtb7E 16352795 (Pubitemid 41785868)
25. Permert J, Adrian TE, Jacobsson P, et al. Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg. 1993;165(1):61-6; discussion 66-7.
26. D Basso L Brigato A Veronesi, et al. 1995 The pancreatic cancer cell line MIA PaCa2 produces one or more factors able to induce hyperglycemia in SCID mice Anticancer Res 15 6B 2585 2588 1:CAS:528:DyaK28Xitl2isbw%3D 8669828
27. D Basso E Greco P Fogar, et al. 2006 Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause? Clin Chim Acta 372 1-2 120 128 10.1016/j.cca.2006.03.027 1:CAS:528:DC%2BD28XovVSks7g%3D 16678810 (Pubitemid 44286765)
28. BB Barone HC Yeh CF Snyder, et al. 2008 Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis JAMA 300 23 2754 2764 10.1001/jama.2008.824 1:CAS:528: DC%2BD1cXhsFalur%2FP 19088353
29. LV van de Poll-Franse S Houterman ML Janssen-Heijnen, et al. 2007 Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis Int J Cancer 120 9 1986 1992 10.1002/ijc.22532 17230509 (Pubitemid 46418378)
30. SM Park MK Lim SA Shin YH Yun 2006 Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study J Clin Oncol 24 31 5017 5024 10.1200/JCO.2006.07.0243 17075121 (Pubitemid 46631405)
31. ME Charlson P Pompei KL Ales CR MacKenzie 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 5 373 383 10.1016/0021-9681(87)90171-8 1:STN:280:DyaL2s7ms1GnsQ%3D%3D 3558716 (Pubitemid 17055592)
32. Social Security Death Index, RootsWeb 2009. http://ssdi.rootsweb. ancestry.com/. accessed February 16, 2009.
33. American Diabetes Association 2009 Diagnosis and classification of diabetes mellitus Diabetes Care 32 Suppl 1 S62 S67 10.2337/dc09-S062
34. TA Sohn CJ Yeo JL Cameron, et al. 2000 Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 6 567 579 10.1016/S1091-255X(00)80105-5 1:STN:280: DC%2BD3Mzlt1yqtA%3D%3D 11307091
35. G Garcea AR Dennison CJ Pattenden, et al. 2008 Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature JOP 9 2 99 132 18326920
36. Kleinbaum D, Klein M. Logistic regression: a self-learning text. New York: Springer; 2002.
37. A Valerio D Basso S Mazza, et al. 2001 Serum protein profiles of patients with pancreatic cancer and chronic pancreatitis: searching for a diagnostic protein pattern Rapid Commun Mass Spectrom 15 24 2420 2425 10.1002/rcm.528 1:CAS:528:DC%2BD38XjtVKhug%3D%3D 11746913 (Pubitemid 34024210)
38. D Basso C Millino E Greco, et al. 2004 Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes Gut 53 8 1159 1166 10.1136/gut.2003.024471 1:CAS:528:DC%2BD2cXmvVehtbw%3D 15247186 (Pubitemid 38961972)
39. D Basso E Greco P Fogar, et al. 2005 Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications Clin Chim Acta 357 2 184 189 10.1016/j.cccn.2005.03.025 1:CAS:528:DC%2BD2MXlslymsr4%3D 15946661 (Pubitemid 40884599)
40. T Meggiato M Plebani D Basso, et al. 1999 Serum growth factors in patients with pancreatic cancer Tumour Biol 20 2 65 71 10.1159/000030049 1:STN:280:DyaK1M7mtVOntw%3D%3D 10050105
41. B Isaksson L Strommer H Friess, et al. 2003 Impaired insulin action on phosphatidylinositol 3-kinase activity and glucose transport in skeletal muscle of pancreatic cancer patients Pancreas 26 2 173 177 10.1097/00006676-200303000- 00014 1:CAS:528:DC%2BD3sXns1Smtr0%3D 12604916 (Pubitemid 36278305)
42. P Fogar C Pasquali D Basso, et al. 1994 Diabetes mellitus in pancreatic cancer follow-up Anticancer Res. 14 6B 2827 2830 1:STN:280:DyaK2M7nslGqsw%3D%3D 7532931
43. O Ishikawa H Ohhigashi A Wada, et al. 1989 Morphologic characteristics of pancreatic carcinoma with diabetes mellitus Cancer 64 5 1107 1112 10.1002/1097-0142(19890901)64:5<1107::AID-CNCR2820640523>3.0.CO;2-Y 1:STN:280:DyaL1Mzjs1Kgug%3D%3D 2758385
44. WE Fisher PJ McCullough MB Ray, et al. 1988 Diabetes enhances growth of pancreatic carcinoma cells Surgery 104 2 431 436 1:STN:280:DyaL1c3ptFSiuw%3D%3D 3400068
45. WE Fisher LG Boros WJ Schirmer 1996 Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors J Surg Res 63 1 310 313 10.1006/jsre.1996.0266 1:CAS:528:DyaK28XksVOms7c%3D 8661216 (Pubitemid 26197211)
46. WE Fisher P Muscarella LG Boros WJ Schirmer 1998 Variable effect of streptozotocin-diabetes on the growth of hamster pancreatic cancer (H2T) in the Syrian hamster and nude mouse Surgery 123 3 315 320 1:STN:280: DyaK1c7oslaksA%3D%3D 9526524
47. O Stoeltzing W Liu F Fan, et al. 2007 Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system Cancer Lett 258 2 291 300 10.1016/j.canlet.2007.09.009 1:CAS:528:DC%2BD2sXhtlagsb7P 17950526 (Pubitemid 350101026)
48. U Bergmann H Funatomi M Yokoyama, et al. 1995 Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles Cancer Res 55 10 2007 2011 1:CAS:528:DyaK2MXls1OlurY%3D 7743492
49. X Ding PR Flatt J Permert TE Adrian 1998 Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin Gastroenterology 114 1 130 138 10.1016/S0016-5085(98)70641-9 1:CAS:528:DyaK1cXks1SjtQ%3D%3D 9428227 (Pubitemid 28020963)
50. AK Ganti A Potti M Koch, et al. 2002 Predictive value of clinical features at initial presentation in pancreatic adenocarcinoma: a series of 308 cases Med Oncol 19 4 233 237 10.1385/MO:19:4:233 12512917 (Pubitemid 36016014)
51. R Talar-Wojnarowska A Gasiorowska J Strzelczyk, et al. 2003 Prognostic factors in the operative and palliative treatment of pancreatic cancer Neoplasma 50 5 383 387 1:STN:280:DC%2BD3srkvVyjug%3D%3D 14628094
52. H Wakasugi A Funakoshi H Iguchi 2001 Clinical observations of pancreatic diabetes caused by pancreatic carcinoma, and survival period Int J Clin Oncol 6 1 50 54 10.1007/PL00012080 1:STN:280:DC%2BD3Mnltlyitg%3D%3D 11706528
53. SS Coughlin EE Calle AV Patel MJ Thun 2000 Predictors of pancreatic cancer mortality among a large cohort of United States adults Cancer Causes Control 11 10 915 923 10.1023/A:1026580131793 1:STN:280:DC%2BD3M7jvVSjuw%3D%3D 11142526 (Pubitemid 32005303)
54. KY Bilimoria DJ Bentrem CY Ko, et al. 2007 Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database Cancer 110 4 738 744 10.1002/cncr.22852 17580363 (Pubitemid 47257648)
55. C Sperti C Pasquali A Piccoli S Pedrazzoli 1996 Survival after resection for ductal adenocarcinoma of the pancreas Br J Surg 83 5 625 631 10.1002/bjs.1800830512 1:STN:280:DyaK283ps1agug%3D%3D 8689203 (Pubitemid 26163547)
56. R Pannala A Basu GM Petersen ST Chari 2009 New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer Lancet Oncol 10 1 88 95 10.1016/S1470-2045(08)70337-1 19111249